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Abstract
Background: Our understanding of disease is increasingly informed by changes in gene expression between normal and
abnormal tissues. The release of the canine genome sequence in 2005 provided an opportunity to better understand
human health and disease using the dog as clinically relevant model. Accordingly, we now present the first genome-wide,
canine normal tissue gene expression compendium with corresponding human cross-species analysis.
Methodology/Principal Findings: The Affymetrix platform was utilized to catalogue gene expression signatures of 10
normal canine tissues including: liver, kidney, heart, lung, cerebrum, lymph node, spleen, jejunum, pancreas and skeletal
muscle. The quality of the database was assessed in several ways. Organ defining gene sets were identified for each tissue
and functional enrichment analysis revealed themes consistent with known physio-anatomic functions for each organ. In
addition, a comparison of orthologous gene expression between matched canine and human normal tissues uncovered
remarkable similarity. To demonstrate the utility of this dataset, novel canine gene annotations were established based on
comparative analysis of dog and human tissue selective gene expression and manual curation of canine probeset mapping.
Public access, using infrastructure identical to that currently in use for human normal tissues, has been established and
allows for additional comparisons across species.
Conclusions/Significance: These data advance our understanding of the canine genome through a comprehensive analysis
of gene expression in a diverse set of tissues, contributing to improved functional annotation that has been lacking.
Importantly, it will be used to inform future studies of disease in the dog as a model for human translational research and
provides a novel resource to the community at large.
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Introduction
The opportunity to study health and disease in the dog (Canis
lupus familiaris) has significantly expanded with the release of the
first public draft of the canine genome. [1,2,3] This opportunity
has been complemented by the development of high throughput
technologies, such as expression and SNP microarrays, now
commercially available for the dog [4,5,6]. Using these techniques
and data, questions and hypotheses related to the health of dogs
and their inclusion in biomedical research can now be articulated
from a post-genomic perspective. [7,8,9] However, our ability to
extend and refine our knowledge is limited due to the lack of a
comprehensive functional assessment of canine gene expression in
diverse sets of normal tissues. [10,11] Rather than repeating this
requisite step in new canine genomic studies, an efficient approach
would be to provide researchers with an openly accessible set of
validated expression profiles from canine normal tissues. A similar
approach has been used for human normal organ gene expression
data on both oligonucleotide and cDNA array platforms.
[12,13,14,15]. A major benefit of these human studies is that
several datasets are publicly available through web-based interac-
tive analytical tools. Based on the same rationale and using a
similar approach, the availability of an online database of canine
normal tissue gene expression profiles would serve as the founda-
tion for in silico analysis of canine diseases thereby increasing the
efficiency and eliminating redundancy. Since the dog represents a
model organism for human disease, the development of such a
database would also enable more rigorous comparative genomic
analysis with gene expression data sets available for human, rat
and murine tissues [2]. Such comparative studies would enable the
identification of common gene regulatory regions as well as
evolutionarily conserved gene expression networks providing a
better understanding of organ functions in normal and diseased
states.
To meet these needs and opportunities, the goal of this project
was to develop a robust, publicly accessible gene expression profile
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Canine Version 2.0 GeneChipH platform. Tissues included: liver,
kidney, heart, lung, cerebrum, spleen, lymph node, jejunum,
pancreas, and skeletal muscle. The informative utility of the
resultant expression data was assessed in several ways. Bioinfor-
matic analysis revealed a large number of differentially expressed
genes based on tissue type. This enabled the identification of gene
expression profiles that were selective for each tissue. Indeed,
hierarchical clustering and principle component analysis using
these profiles demonstrated that organs grouped together based on
shared function and structural composition. Consistent with these
observations, analyses of tissue selective genes were suggestive of
tissue origin, function and physiology. Importantly, analysis of
canine and human orthologous gene expression in matched tissues
revealed remarkable similarity between species. These normal
tissue expression data and the demonstration of shared ortholo-
gous expression patterns in humans allowed redefinition of canine
Affymetrix probesets not previously mapped to a known transcript.
In the future, this data should aid in expanding and refining canine
gene ontologies allowing a much more robust assessment of
biological functions associated with co-regulated gene sets in each
tissue.
This data is now publicly available for use through the esta-
blishment of a Canine Normal Tissue Database (ccr.cancer.gov/
resources/cop). This database allows for gene specific queries of
normal tissues in the dog as well as cross species comparison of
gene expression between canine and human tissues. We anticipate
this dataset will provide the foundation for more advanced study of
disease in the dog and improve biomedical studies that utilize the
dog as a model for translational research.
Results
Validation of an Informative Database of Normal Canine
Tissues: Identification of Organ Selective Gene Expression
Signatures
Previous studies have cataloged global gene expression patterns
for normal tissues in pig, mouse, rat and human.
[12,15,16,17,18,19,20,21] The dog is an excellent model for
many human diseases, however little is known about canine gene
expression across diverse tissues. Therefore, ten organs from four
dogs were harvested and RNA purified for analysis using
Affymetrix Canine Version 2.0 arrays. This array consists of
42,860 canine probesets corresponding to over 18,000 mRNA/
EST based transcripts and over 20,000 non-redundant predicted
genes (www.affymetrix.com). [4]
A comparison of gene expression profiles for ten normal canine
organs was undertaken using an ANOVA model to assess the
informative value of this data set. Consistent with previous studies
in humans, .50% of all canine probesets (23,070) demonstrated
differential expression based on tissue type and this corresponds to
10,878 unique gene symbols. [15,19,20] To further validate the
utility of these data and to characterize relationships between
biological replicates, samples were analyzed by principle compo-
nent analysis (PCA) (Fig. 1A and Fig. S1) and hierarchical
clustering (HC) (Fig. 1B) using those probesets differentially
expressed in at least one tissue. As shown in Fig. 1A samples
grouped according to organ type with greater than 47% of the
variability explained by the first three principle components.
Multi-level bootstrap re-sampling was then conducted on
hierarchical clustering results in order to determine the reproduc-
ibility of cluster assignment. As shown in Fig. 1B, replicate
samples again grouped together according to organ type (.95%
confidence at each branch point). Identical results were observed
when using all probesets (data not shown). In addition, tissues with
a common developmental origin and/or anatomical function
grouped together. For example, mesoderm derived heart and
skeletal muscle group together as do the functionally related
immune organs lymph node and spleen.
A further assessment of the quality and informative value of the
data was provided by defining contrasts as part of the ANOVA
model. Probe sets that were differentially expressed in one tissue
versus all others were identified following correction for multiple
testing (FDR, 0.001). The number of differentially expressed
probesets in each tissue, as well as the corresponding number of
unique gene symbols, are shown in Table S1. Next, we used a
series of filtering steps, as described previously, to identify those
genes exhibiting the greatest organ selective expression profile.
[21] First, for each organ, probesets expressed greater than 10-fold
over the mean of all other tissues were identified. For most tissues,
this represented approximately 5–10% of the original number of
significant probesets. The extreme cases were pancreas in which
only 1% of the probesets achieved this threshold and liver in which
14% of the probesets were greater than 10-fold over the mean of
all other tissues. A second filtering threshold, no greater than 3-
fold expression over the mean in any other tissue, was defined to
arrive at a final list of the most organ defining genes (Fig. 1C).
Lymph node had the smallest number of selective probesets (24),
whereas brain exhibited the greatest number (512). The spleen
shares many overlapping cell types and immune functions with
lymph node and accordingly, shares a similar gene expression
signature (Fig. 1A and B). Functionally, the brain (cerebrum in
this study) represents the most anatomically and physiologically
unique structure, therefore it is not surprising to find the greatest
number of tissue selective genes expressed in this tissue. As
expected, top organ defining genes included those previously
associated with the physiologic function of that organ (Lung
example: Table S2).
Validation of Microarray Derived Organ Defining Genes
through Quantitative RT-PCR
Quantitative RT-PCR was used to validate the microarray
results. Genes were selected for validation, which were described
in the previous analysis as organ defining (UMOD, Uromodulin-
kidney; LIPC, Hepatic Lipase-liver; RTN1, Reticulon 1-brain).
Transcripts exhibited expected tissue selective expression patterns
with differential expression even higher by QT-PCR vs. micro-
array. (Fig. S2). Overall, pattern and magnitude of expression
across tissues compared to house keeping controls for each
validation gene illustrated concordance across platforms.
Validation of an Informative Database of Normal Canine
Tissues: Functional Assessment of Organ Selective Gene
Sets
One of the primary limitations predicted and observed during
the course of our analysis was the relative lack of functional
annotation for canine probesets and corresponding transcripts
using resources such as NetAffx
TM, Ensembl and Entrez Gene.
[22,23,24] For example, of the 42,860 non-control probesets on
the Affymetrix Canine Version 2.0 GeneChipH, only 2,726 (6.4%)
have at least one GO term associated. The frequency of GO term
annotation is even lower when examining the tissue selective
probeset lists such as canine brain where, out of 512 probesets,
only 18 (3.5%) are currently annotated with GO terms. This limits
the ability to get significant results when using default canine
transcript annotations for functional analysis of overrepresented
GO terms.
Canine Comparative Genomic Modeling
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approach to more completely annotate canine transcript informa-
tion. Blast2GO-FAR (B2G-FAR) is a species-centered functional
annotation repository enabling whole genome and Affymetrix
platform specific transcript annotation. [22,23,24,25] To the best
of our knowledge, this resource provides the most extensive high-
quality canine probeset and transcript annotations. Compared to
NetAffx
TM (6.4% probeset annotation), the B2G-FAR annotation
file contains GO terms for 49.4% of all non-control probesets and
more than 142,000 annotations total for the canine array. Next,
we conducted functional enrichment analysis using tissue selective
probeset lists for each organ. Analysis was conducted in Blast2GO,
which uses GOSSIP to perform a one-sided Fisher’s exact test with
a modified false discovery rate (FDR) or family wise error rate
(FWER) calculation to correct for multiple testing. [26] B2G-FAR
annotations were used for the functional analysis of canine tissue
selective probeset lists and complete results for the brain are shown
in Table S3. For each organ, the top overrepresented GO terms
(FDR 0.05) described known functions for the tissue as expected.
For example, the brain selective probeset list was overrepresented
by GO terms such as neurogenesis, synaptic transmission, neuron
projection and other neuronal associated functions and processes.
Canine kidney was largely characterized by GO terms describing
anion/cation transport as well as brush border and other
membrane related terms. The immune organs spleen and lymph
node were analyzed together and, as expected, were described by
GO terms such as immune response, chemokine activity and
response to stress. Pancreas was characterized by GO terms
representing digestion, cholinesterase and other enzymatic activity
as well as extracellular region/space. The most specific liver
associated GO terms were microsome/ER membrane, heparin
and heme binding and complement activation, classical pathway.
Canine jejunum was described by GO terms such as apical plasma
membrane, intestinal absorption, microvillar actin bundle forma-
tion and various transporter related functions as expected for this
organ. Canine lung was characterized by the fewest number of
overrepresented GO terms, primarily regulation of liquid surface
tension, respiratory gaseous exchange and extracellular region/
space. Notably, the heart selective gene list specifically described
cardiac functions which did not overlap with the skeletal muscle
tissue selective gene list even though both tissues share many other
overlapping GO terms representing general striated muscle
function and striated muscle components.
Taken together, the results of our gene expression and
functional analysis suggest that the canine normal tissue dataset
accurately reflects a biologically meaningful transcriptional profile
for each tissue. Furthermore, the analysis of the canine data set
using B2G-FAR supports the value of this investigative tool for the
functional annotation of data sets where complete conventional
annotation is not yet available.
Cross-Species Comparisons Between Canine and Human
Orthologs
Orthologous genes are derived from a common ancestral gene
and retain similar function. Therefore, it is expected that a
comparison of canine and human orthologous gene expression, in
matched tissues, should result in clustering based on tissue rather
than by species. In order to test this hypothesis, we analyzed
Affymetrix human U133A raw data previously published as part of
the Novartis Human Normal Tissue Compendium. [20] In cases
where there were no matched tissues (jejunum and spleen), raw
data in the form of .CEL files were collected from the Gene
Expression Omnibus (GEO). [27] Expression values for the
human normal tissue data set were determined using identical
analysis parameters to the canine normal tissue data (see
Methods). Next, both the human and canine data sets were
filtered to retain only best sequence matched orthologous
probesets, as defined using the Affymetrix Netaffx
TM website. In
cases where there were more than one probeset representing the
same gene symbol, the maximum expression value was used so
that there was only a single expression measure for each gene.
Expression measures for each gene were z-score transformed for
each species independently to allow for subsequent comparison on
the same scale. The two datasets were then merged by matching
gene symbols resulting in standardized expression measures for
2,598 transcripts.
As shown in Fig. 2A, hierarchical clustering with bootstrap
resampling revealed that samples mainly grouped together based
on tissue type rather than by species. In addition, sample grouping
was consistent with overlapping anatomical functions and/or
cellular composition. For example, lymph node, spleen and lung
grouped together in a clade separate from all other tissues (branch
point 13). These tissues grouped similarly based on shared
expression of genes involved in immune response/functions.
Canine lung and spleen were the only two examples of ambiguous
cluster assignment at the final branch point. Brain, skeletal muscle
and heart also form a distinct clade (branch point 17) while kidney,
liver, pancreas and jejunum group together in a final cluster
(branch point 16). These results are consistent with our previous
hierarchical cluster analysis using all canine tissue replicates and
more than 10,000 probesets (Fig. 1B). In addition, these results
suggest that orthologous canine and human genes share similar
tissue enriched and/or tissue selective expression patterns. Next, a
multi-factor ANOVA was conducted in order to determine genes
differentially expressed based on tissue. After correcting for
multiple testing (FDR=0.001), this resulted in the identification
of 294 transcripts which were then analyzed by hierarchical
clustering to find tissue enriched and tissue specific orthologous
gene clusters. As shown in Fig. 2B, the overall structure of sample
clustering remained the same with the notable exception being
brain, which now separated into a distinct branch due to the high
Figure 1. Principle component analysis and hierarchical clustering define relationships between canine normal tissues. mRNA
expression for 39 samples from ten pathologically normal canine tissues were analyzed using the Affymetrix Canine Version 2.0 GeneChipH. Probesets
differentially expressed in at least one tissue (as described in the Methods) were included in the analysis (23,070 probesets corresponding to 10,878
unique gene symbols). A. Samples were analyzed by principle component analysis (PCA) to characterize relationships between biological replicates
for each tissue. Each sphere represents an individual sample, colored by tissue and ellipses correspond to two standard deviations of the tissue group
mean. B. Hierarchical clustering of samples was conducted with distances calculated using Pearson correlation metrics and clusters joined using Ward
linkage. Bootstrap re-sampling was conducted (1,000 iterations) in order to determine cluster stability. C. Heatmap demonstrating tissue selective
gene expression. Following ANOVA to determine differential expression based on tissue type, results were filtered based on FDR=0.001 as well as
expression thresholds of greater than 10-fold expression over the mean of all other tissues and no greater than 3-fold over the mean in any other
tissue. This final list of tissue selective probesets was rank ordered according to fold-expression with sample order determined by the previous
bootstrapped hierarchical clustering. Red indicates upregulated and green represents downregulated relative to the mean expression in all tissues.
Numbers next to the heatmap indicate the number of tissue selective probesets in a cluster.
doi:10.1371/journal.pone.0017107.g001
Canine Comparative Genomic Modeling
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tissues. Taken together, this comparative analysis provides further
validation of the quality and consistency of the canine expression
dataset and suggests the opportunity to add value to the data set
from cross-species analysis.
Using Normal Tissue Gene Expression Data and
Comparative Genomics to Redefine Affymetrix Canine
Probeset Annotation
A limitation encountered during our study was the large number
of probesets for which no canine gene has been assigned (Table
S1). Out of the 42,860 total probesets on the canine version 2.0
array, 11,339 (27%) have no gene symbol or gene name attributed
using NetAffx
TM annotations. In order to demonstrate that these
unidentified probesets, alone, can provide important information
regarding tissue selective gene expression we conducted principle
component analysis. As shown in Fig. 3A, these probesets, without
any prior filtering, were able to clearly separate sample replicates
based on tissue. This was especially true for canine brain, pancreas,
skeletal muscle and heart. However, it is unclear which transcripts
these probesets are assessing and since many are highly expressed in
a tissue selective manner it would be of interest to know this
information.Asa proofofconcept,wedeveloped anapproachtore-
map a subset of the top brain selective probesets for which no gene
identifying information was available. This serves to describe a
process for further annotation of canine transcripts and genes across
all tissues, normal and diseased.
First, Affymetrix probeset identifiers were used to query
Ensembl where genomic and transcript linked information was
gathered. For example, canine probeset, Cfa.11188.1.A1_at,
aligned to a region immediately 39 to, but not included as part
of, the predicted canine SV2B gene (Fig. 3B). This may explain
the lack of gene symbol, gene name or GO term annotations using
Netaffx
TM. Next, a BLASTZ pairwise alignment between the
canine and human genomic sequences revealed this region to be
syntenic to human chromosome 15. [28] Additional features were
mapped to the pairwise alignment including the position of other
canine or human probesets for the locus as well as canine EST
evidence and known human transcripts.
SV2B, synaptic vesicle glycoprotein 2B, is a known 1-to-1
canine/human ortholog listed in both the Ensembl and Homo-
logene databases and shares 91.9% nucleotide sequence identity
and 95.6% at the amino acid level for the predicted protein
product [24]. Closer inspection of the gene structure, including
intron/exon boundries and non-coding sequences, revealed the
primary difference between the two gene annotations was the
shorter predicted length of the 39 untranslated region (UTR) in
canine, even though this region is highly conserved. The
automated gene annotation process currently employed by
Ensembl uses a default UTR length, calculated as the highest of
either the mean or the median of all annotated UTRs for a given
species [22]. However, multiple lines of EST and ortholog
expression evidence suggest the canine SV2B 39 untranslated
region may extend further than predicted. Through Bio-GPS/
Novartis Symatlas (http://biogps.gnf.org) physical mapping of
human SV2B exhibits a highly brain specific expression pattern. In
addition, canine probeset, Cfa.11188.1.A1_at, physically aligns to
the same orthologous region as the human Affymetrix U133A
probeset 205551_at. Interestingly, NetAffx
TM does list a different
canine probeset for the SV2B gene, CfaAffx.17603.1.S1_at, which
maps to the predicted protein coding sequence. However, only
10/11 probes match the CanFam 2.0 genome assembly and the
individual probes are spread out over multiple exons (Fig. 3B). In
addition, the expression values for this probeset in all canine
samples, regardless of tissue, are extremely low (Fig. 4). One
possibility is that one or more exons are alternatively spliced
resulting in decreased sensitivity for this probeset.
Taken with our assessment of its tissue selective expression
pattern, our results support an alternative probeset annotation for
the SV2B gene. This manual annotation process was repeated for
the 21 remaining canine probesets with no gene symbol in the
brain top 50 tissue selective probeset list (Table S2). A heatmap
representing mean centered expression values for these probesets,
demonstrating their tissue selectivity, is shown in Fig. 4.
Additional examples of the manual curation process for these
probesets are shown in Fig. S3, S4, S5, S6. This was done to
demonstrate proof-of-concept for our approach and to provide an
example for how this canine normal tissue expression data can be
used for comparative genomic studies.
Establishment of a Canine Normal Tissue Database
A publicly available, web accessible database (Canine Normal
Tissue Database) was created from this dataset to allow other
researchers to query individual gene expression across canine
normal tissues. This database is available through the NCI Com-
parative Oncology Program website ccr.cancer.gov/resources/
cop. Raw data (Affymetrix .cel files) can also be downloaded
directly from this site for use as controls in other canine genomic
analyses. The Canine Normal Tissue Database was developed to
allow parallel viewing of gene expression with the (human)
Oncogenomics Normal Tissue database, available via a web-based
interface described previously ntddb.abcc.ncifcrf.gov/cgi-bin/
nltissue.pl [15].
Discussion
This work represents the first compiled dataset of canine normal
organ gene expression profiles. In order to provide a descriptive
dataset we used several biological replicates per organ representing
both pure bred (beagle) and mixed breed dogs of both sexes and of
varying ages. The ten tissues chosen for this study represent a
broad selection of organs that are informative across research
communities involved in canine health and disease as well as those
interested in toxicogenomics or comparative genomics.
Figure 2. Hierarchical clustering defines relationships between canine and human normal tissues. Orthologous probesets from canine
and human Affymetrix gene expression platforms were mapped using NetAffx
TM ‘‘best sequence’’ matches. In cases where there were multiple
probesets representing the same gene symbol, the one with highest expression was used. This resulted in a total of 2,598 expression measures for
comparison between species. No prior information about differential expression was used. The only filtering done was to exclude probesets in each
species that were not expressed in at least one tissue. A. Hierarchical clustering of canine and human matched tissues based on 2,598 sequence
matched orthologous probesets. Sample distances were calculated using Pearson correlation metrics and clusters joined using Ward linkage.
Bootstrap re-sampling was conducted (10,000 iterations) in order to determine cluster stability. Confidence measures for multi-level bootstrap
analysis are based on approximately unbiased p-values (AU), and simple bootstrap analysis probabilities (BP) for each node of the dendrogram, which
are labeled numerically. B. Hierarchical clustering of samples and genes was conducted using 294 probesets differentially expressed in at least one
tissue based on multi-factor ANOVA (species and tissue). Euclidean distance measure and complete linkage was used for clustering. Within the
heatmap, red denotes greater relative expression whereas green denotes lower.
doi:10.1371/journal.pone.0017107.g002
Canine Comparative Genomic Modeling
PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e17107Figure 3. Resolution of transcript assignment for canine probesets mapping to the SV2B gene locus. A. Principle component analysis of
all 11,339 canine probesets with no gene identifier associated. B. Ensembl BLASTZ pairwise genomic alignment of human chromosome 15 (top
panel) and canine chromosome 3 (bottom panel) centered on the 39 region of the SV2B gene locus. Affymetrix human U133A probeset, 205551_at
(SV2B), and canine_2 probesets, CfaAffx.17603.1.S1_at (SV2B) and Cfa.11188.1.A1_at (unidentified) are aligned to their corresponding genomic
regions. Canine EST evidence is shown in purple.
doi:10.1371/journal.pone.0017107.g003
Canine Comparative Genomic Modeling
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dataset was supported in several ways. Organ defining expression
data and functional analysis distinguished normal canine tissues.
Analysis of expression profiles, by principle component analysis
and bootstrapped hierarchical clustering, established that biolog-
ical replicates grouped together based on tissue of origin
demonstrating internal consistency in the dataset. In addition,
each organ clustered in a manner consistent with anatomical
function and/or cellular composition, similar to what has been
published previously for human studies [12,13,14,15]. These
results were further supported by our analysis of canine and
human orthologous gene expression which demonstrated repro-
ducible clustering based on organ type driven by tissue enriched
and tissue selective gene expression profiles. The identification of
gene expression profiles with similarity to published human data
allowed us to further demonstrate the value of this dataset by
informing canine gene and probeset annotation. Exemplified by
our annotation of brain specific transcripts, we demonstrated that
gene identifiers can now be more confidently linked to previously
unknown probesets so as to yield a more complete and functional
view of canine gene expression across all tissues.
Toenableresearchers’accesstothiscomprehensivedataset,aweb
accessible database was constructed. This allows users to quickly and
easily evaluate gene expression across canine tissues using various
gene identifiers. In addition, comparative gene expression analysis
can be conducted between canine and human normal tissue gene
expression. Raw data is also available from this web interface and
can be used as uniform normal tissue controls and comparators in
future canine genomic analyses as well as for end user specific pre-
processing options. Use of the Affymetrix Canine Version 2.0
GeneChipH platform for this study enables a standardized approach
for further database growth. Additional samples can easily be
incorporated inthe futureincluding an expandedrepertoire oforgan
samples as well as experimental data representing diseased tissue
from matched canine organs. This gene expression dataset will be of
interest to both basic and translational scientists interested in
understanding canine health anddiseaseand to advance the dogasa
post-genomic species used in biomedical research.
The public release of the canine genome draft in 2005 was
pivotal in advancing the study of disease in the dog by broadening
the opportunity for advanced high throughput ‘‘omic’’ analyses
[2]. This genomic sequencing data, together with the development
of the Affymetrix Canine Version 2.0 GeneChipH, provided the
opportunity to develop a canine normal tissue gene expression
database. One of the goals of the National Cancer Institute’s
Comparative Oncology Program (NCI-COP) is to include
companion animals with cancer in the mainstream of cancer
research [1,5,29]. One of the mechanisms for accomplishing this
goal is through careful genomic and proteomic analysis of cancers
in dogs. Interest by academia, industry and regulatory agencies has
fueled new collaborations between the human and animal health
communities to understand and treat cancer in the dog. These
expanding relationships provide an opportunity for a win-win
outcome for dogs and humans. We believe the establishment of a
canine normal tissue expression database and its public availability
will play an integral role in advancing the study of canine disease
as well as enable inter-species comparisons of common diseases. In
doing so, this promises to improve the health of dogs and humans
with cancer and other diseases. [8,30]
The need for canine normal tissue expression database emerged
from challenges presented to us in our own work in comparative
genomics, initially in osteosarcoma [31]. The interpretation of
comparative genomic data requires an understanding of the gene
expression profiles of normal human and canine tissues.
Furthermore, improvements in gene and transcript annotation
are necessary to more completely define data emerging from gene
expression experiments. The opportunity to rapidly query an
existing and robustly annotated database of normal canine tissues
would have hastened the completion of our studies and
substantially reduced costs. Our previous work is an example of
many similar studies that would benefit from a common
characterization of canine normal tissues. [7,9,32,33,34]
In summary, this work establishes a validated database of canine
normal tissue gene expression data making genomic characteriza-
tion of diseased states in the dog, like cancer and others, less
expensive and expedient. This publicly available database can be
queried for canine and human gene expression patterns across
matched normal tissues. It is our expectation that this data will
lead to improvements in our understanding of diseases and
conditions that afflict both dogs and humans.
Materials and Methods
Canine tissue samples
Forty (40) pathologically normal organ samples were collected
from four dogs, 10 organs from each dog. They included two
males and two females ranging in age from 3 months to 6 years of
age. Two of the animals were beagles and two were mixed breed
dogs. Organ samples included the pancreas, kidney, liver, lung,
heart, skeletal muscle, jejunum, cerebrum, spleen and peripheral
lymph node. Samples were collected and frozen in RNAlaterH
within 30 minutes of collection. All samples were stored at – 80uC
until processing.
RNA extraction and Affymetrix microarray processing
RNA was extracted from all samples using TRIzolH according
to manufacturers instructions (Invitrogen, Carlsbad, CA). Samples
were then further purified using Qiagen miniprep RNA clean up
(Qiagen, Valencia, CA) as per Affymetrix protocols for array
preparation. Samples were quantified and assessed for quality
using a Bioanalyzer 2100 instrument (Agilent Technologies, Palo
Alto, CA). Five micrograms of purified RNA was reverse
transcribed and used to make cRNA. Samples were hybridized
to Canine Genome Version 2.0 Affymetrix oligonucleotide arrays
according to manufacturers instructions (Affymetrix, Santa Clara,
CA) at the NCI Microarray Core Facility (Frederick, MD).
Analysis of canine differential gene expression
Affymetrix .cel files containing the raw, probe level signal
intensities, were analyzed using PartekH software, version 6.4 (build
Figure 4. Use of canine-human comparative genomics and expression analysis to improve annotation of canine probesets. Canine
brain had the greatest number of probesets without a gene symbol or gene name assigned. As proof-of-concept, these probesets within the top 50
canine brain selective list were re-mapped and underwent manual curation to link transcript information to expression data. Heatmap representing
expression values for NetAffx
TM unassigned canine probesets (NA) as well as LOC designated probesets in the top 50 brain selective expression list.
Following manual curation the newly assigned gene symbols (curated gene symbol) are shown. Once these probesets were mapped to a known
transcript, all other canine probesets for that transcript on the canine version 2.0 array were subsequently re-mapped and their relative expressioni s
shown for comparison. In cases where the curated gene symbol is represented by (NA), this denotes that the probeset mapped unambiguously to an
intronic region. Red represents increased and green decreased log-fold expression compared to the mean of all other tissues.
doi:10.1371/journal.pone.0017107.g004
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Partek Inc. product or service names are registered trademarks or
trademarks of Partek Inc., St. Louis, MO, USA.). Robust multichip
averaging (RMA) was used for pre-processing of probe level data
(using only interrogating probes) including pre-background adjust-
ment for GC content and probe sequence followed by RMA
background correction. All chips underwent quantile normalization
and probeset summaries were median polished [35].
Analysis of variance (ANOVA) was used to determine
statistically significant differences in probeset signal intensities
between organ types. Categorical variables included in the
ANOVA model were tissue type and scan date (random variable).
Contrasts included single tissues versus the remaining nine tissues.
Adjusted p-values were obtained using a Benjamini-Hochberg
step-up procedure to control the false discovery rate (FDR) (set at
0.001) [36]. Least-square mean signal intensities were used in the
analysis in order to account for the unbalanced experimental
design following exclusion of the single pancreas sample. Lists of
differentially expressed probesets for each organ were generated
based on FDR corrected p-values obtained from contrasts built
into the ANOVA model. These lists were further filtered to
identify tissue selective genes using an arbitrary cut-off of greater
than 10-fold increased in one organ compared to the median
expression value in all other organs and no greater than 3-fold
over mean expression in any other tissue.
Principle component analysis
To analyze the relationships of all canine sample replicates as a
means of identifying outliers, we conducted principle component
analysis on all samples and probesets initially (Fig. S1). This
assessment revealed a single sample (one pancreas sample) to be an
outlier based on the relative distribution of all other replicates for
each tissue as well as the other three biological replicates for the
pancreas and lack of expression of classic pancreatic genes such as
insulin, pancreatic secretory trypsin inhibitor precursor, elastase 1
and carboxypeptidase B1 (data not shown). Therefore, we
repeated the Affymetrix .cel file import process using the
remaining 39 samples and re-processed the data as above.
Quantitative RT-PCR Validation
For quantitative RT-PCR validation of microarray results, an
independent set of RNA from each of nine tissues was purchased
commercially (Zyagen Laboratories, San Diego, CA). cDNA
synthesis reactions were conducted using 100ng of total RNA and
reverse transcribed using the iScriptTM cDNA synthesis kit
according to manufacturers instructions (Bio-Rad, Hercules, CA).
Diluted cDNA (1:3) was used as template for Taqman based PCR
reactions using the iQTM Supermix according to manufacurers
instructions (Bio-Rad, Hercules, CA). The final concentration of
each primer was 500 nM and each probe 250 nM for all primer/
probe combinations. PCR reactions were conducted using an iQ5
thermocycler (Bio-Rad, Hercules, CA). Thermocycling conditions
were as follows: 95C for 3 minutes followed by 35 cycles of 95C for
5 seconds and 60C for 25 seconds. For quantitation, samples were
normalized using 18S as the reference and each sample was
compared to the group mean threshold cycle value in order to
determine normalized, log-fold expression. [37] The following
transcript specific oligonucleotide primers and 59-6-FAM-internal
ZEN-39-Iowa BlackH probes were synthesized by Integrated DNA





















Agglomerative hierarchical clustering of biological replicates was
done following ANOVA using probesets filtered on FDR (0.001)
corrected p-values. In cases where there were multiple probesets for
the same gene symbol, the maximum intensity value was used to
arrive at a single expression measure for each gene. Gene expression
values were median centered and normalized to a standard deviation
of 1. Between sample and between gene distances were calculated
using Pearson dissimilarity as the measureand Ward linkage was used
to join clusters unless otherwise noted. For between sample
comparisons, bootstrap re-sampling (either 1,000 or 10,000 iterations
as indicated) was conducted in order to determine the stability of
clustering results using the pvclust package implemented in the R
statistical programming environment [38]. Two types of p-values
were included in the results. (AU) approximately unbiased values
were derived from multi-scale bootstrap analysis and (BP) bootstrap
probability values were derived from normal bootstrap re-sampling.
Genome database information used for this study
For analysis in Ensembl, UCSC and NCBI, information from
the human genome build GRCh37 (hg18) was used. For canine,
the CanFam2.0 canine genome assembly was used. Canine-
human genome alignments were generated by pairwise BLASTZ
alignment and visualized using Ensembl tools [22,28]. Syntenic
regions of canine and human chromosomes were determined
using Ensembl as well as through the Broad Institute Alpheus
website (http://www.broadinstitute.org/,mclamp/alpheus/).
Canine gene annotations
Initial canine probeset annotations, including gene ontology
(GO) terms and mapping of gene identifiers, were done using the
Canine Version 2.0 annotation file (Canine_2.na29.annot.cvs,
released July, 2009) from the Affymetrix Netaffx
TM website at
www.affymetrix.com/netaffx [23]. When indicated in the text,
custom annotations for the Affymetrix Canine Version 2.0
GeneChipH were obtained from B2G-FAR, the Blast2GO
functional annotation repository at http://bioinfo.cipf.es/b2gfar/
affychips:canine [25,39]. The top 50 canine brain selective
probesets without previously assigned gene symbols, or those
having ambiguous gene descriptors were mapped using ENSMBL
probeset to genome alignments followed by manual curation.
Individual probesets were analyzed for: (1) unambiguous align-
ment to the canine genome; (2) mapping to syntenic regions based
on canine-human alignment; (3) physical mapping to matching
human Affymetrix probesets where tissue selective expression
could be verified through Symatlas at http://biogps.gnf.org; (4)
EST based evidence; (5) expression comparison with other
previously identified and Affymetrix annotated canine probesets
Canine Comparative Genomic Modeling
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39UTR alignment with human.
Functional assessment of tissue selective gene sets
Canine tissue selective probesets, as well as all non-control
probesets on the array, were also annotated using B2G-FAR
Affymetrix Canine Version 2.0 GeneChip custom annotations
[25,39]. The annotation file was implemented in Blast2GO
followed by enrichment analysis using GOSSIP (http://gossip.
gene-groups.net) [26]. A one-sided Fisher’s exact test was conduc-
ted to find over-represented GO terms for the canine brain (test
list) using the rest of the array as the reference list. Results are
reported with uncorrected p-values as well as values adjusted for
multiple comparison using false discovery rate and family wise
error rate as described at http://home.clara.net/sisa/fishrhlp.htm.
Comparison of canine and human orthologous gene
expression
In order to analyze data between different Affymetrix platforms
and species, canine-to-human ortholog probeset matches were
identified using the Affymetrix Netaffx
TM website at www.
affymetrix.com/netaffx. Probesets from the Affymetrix Canine
Version 2.0 GeneChipH were mapped to human orthologous
probesets on the Affymetrix Human HG-U133A GeneChipH to
allow for cross-species comparisons of matched organs using
publicly available human gene expression data obtained via the
Gene Expression Omnibus (GEO) at http://www.ncbi.nlm.nih.
gov/geo [4]. Human brain GSM44690, human liver GSM35982,
human spleen GSM35999, human skeletal muscle GSM244532,
human heart GSM44671, human jejunum GSM44679, human
kidney GSM44675, human lung GSM35985, human liver
GSM51371, human pancreas GSM18977. Human .cel file data
for each organ was pre-processed as described for canine data
using using PartekH software, version 6.4. The final list of best
sequence matched, orthologous probesets, as defined by Affyme-
trix NetAffx
TM, for canine and human were consolidated based on
matching gene symbols using maximum expression values in cases
where more than one probeset matched the same gene symbol. In
addition, for each species, each probeset was considered for
analysis only if there was demonstration of expression in at least
one tissue. This resulted in a final list of 2,598 expression measures
for comparison. The signal intensities for each species were then
standardized independently using z-score transformation and then
the data from both species was merged to a single dataset.
Supporting Information
Figure S1 Principle component analysis define relation-
ships between canine normal tissues and identifies one
pancreas outlier. mRNA expression for 40 samples from ten
pathologically normal canine tissues were analyzed using the
Affymetrix Canine Version 2.0 GeneChipH. Only probesets
differentially expressed in at least one tissue (as described in the
Methods) were included in the analysis. Each sphere represents an
individual sample, colored by tissue and ellipses correspond to two
standard deviations of the tissue group mean. A single pancreas
sample was excluded from further analysis.
(TIF)
Figure S2 Log-fold difference compared to the group
(all tissues) mean for three organ-defining genes via
quantitative RT-PCR validates microarray data results.
Genes selected for microarray results validation were previously
described as organ defining (UMOD, Uromodulin-kidney; LIPC,
Hepatic Lipase-liver; RTN1, Reticulon 1-brain). UMOD expres-
sion in the canine kidney is 13.6 fold higher, LIPC expression 8.0
fold higher in the canine liver, and RTN1 expression 11.1 fold
higher in the canine cerbreal cortex via QT-PCR than the group
mean of all other canine tissues. Transcripts exhibited expected
tissue selective expression patterns with differential expression
even higher by QT-PCR vs. microarray.
(TIF)
Figure S3 Resolution of transcript assignment for
canine probesets mapping to the AMPH gene locus. A.
Ensembl synteny map of canine chromosome 18 and human
chromosome 7 highlighting the SV2B gene locus in each species.
B. Ensembl BLASTZ genomic alignment of human chromosome
7 (top panel) and canine chromosome 18 (bottom panel) centered
on the 39 region of the amphiphysin (AMPH) gene locus.
Affymetrix human U133A probeset, 205257_s_at (AMPH), and
canine_2 probesets, Cfa.9875.1.A1_at (unidentified) and CfaAffx.
6381.1.S1_s_at (AMPH) are aligned to their corresponding
genomic regions. Canine EST evidence is shown in purple.
(TIF)
Figure S4 Resolution of transcript assignment for canine
probesets mapping to the DNM3 gene locus. A. Ensembl
synteny map of canine chromosome 7 and human chromosome 1
highlighting the dynamin 3 (DNM3) gene locus in each species. B.
Ensembl BLASTZ genomic alignment of human chromosome 1
(top panel) and canine chromosome 7 (bottom panel) centered on
the 39 region of the DNM3 gene locus. Affymetrix human U133A
probeset, 209839_at (DNM3), and canine_2 probeset, Cfa.10627.
1.A1_at (unidentified) are aligned to their corresponding genomic
regions. Canine EST evidence is shown in purple.
(TIF)
Figure S5 Resolution of transcript assignment for
canine probesets mapping to the DCLK1 gene locus. A.
Ensembl synteny map of canine chromosome 25 and human
chromosome 13 highlighting the doublecortin-like kinase 1
(DCLK1) gene locus in each species. B. Ensembl BLASTZ
genomic alignment of human chromosome 13 (top panel) and
canine chromosome 25 (bottom panel) centered on the 39 region of
the DCLK1 gene locus. Affymetrix human U133A probesets,
215303_at (DCLK1) and 205399_at (DCLK1), and canine_2
probesets, Cfa.11018.1.A1_at (unidentified), Cfa.10440.1.A1_at
(unidentified), CfaAffx.10325.1.S1_at (unidentified), CfaAffx.
10346.1.S1_at (DCLK1) and CfaAffx.10333.1.S1_s_at (DCLK1)
are aligned to their corresponding genomic regions. Canine EST
evidence is shown in purple.
(TIF)
Figure S6 Resolution of transcript assignment for
canine probesets mapping to the NRSN1 gene locus. A.
Ensembl synteny map of canine chromosome 35 and human
chromosome 6 highlighting the neurensin 1 (NRSN1) gene locus
in each species. B. Ensembl BLASTZ genomic alignment of
human chromosome 6 (top panel) and canine chromosome 35
(bottom panel) centered on the 39 region of the NRSN1 gene
locus. Affymetrix human GNFh probeset, 239293_at (NRSN1)
and canine_2 probesets, CfaAffx.16031.1.S1_at (NRSN1),
Cfa.11177.1.A1_at (unidentified), are aligned to their correspond-
ing genomic regions. Canine EST evidence is shown in purple.
(TIF)
Table S1 Differentially expressed probesets and corre-
sponding unique gene symbols in canine tissues.
Describes the number of differentially expressed probesets and
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organs examined in this dataset.
(DOC)
Table S2 Canine lung selective probesets rank ordered
with Fold Change vs. all tissues included. Defines probesets
specific to the canine lung, and is an example of tissue selective
ranking of probesets conducted for each of the ten canine organs
examined in this dataset.
(DOC)
Table S3 Canine Brain Selective Probesets Over Rep-
resented GO Terms. Defines over-represented GO terms in
the canine brain, and is an example of the process used to define
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